Skip to main content
Erschienen in: African Journal of Urology 1/2023

Open Access 01.12.2023 | Original Research

Evaluating the pattern of antibiotic resistance of urinary tract infection (UTI)-causing bacteria in the urine culture samples of patients in the infectious ward of Imam Khomeini Hospital, Kermanshah, in Iran from 2016–2018

verfasst von: Maria Shirvani, Ali Keramati, Mojtaba Esmaeli

Erschienen in: African Journal of Urology | Ausgabe 1/2023

Abstract

Background

Increasing resistance of bacteria to antimicrobial agents is a significant problem worldwide. This study aimed to assess the pattern of antibiotic resistance among bacteria that cause urinary tract infections (UTIs) in patients admitted to the infectious ward of Imam Khomeini Hospital in Kermanshah between 2016 and 2018, based on urine culture samples.

Methods

The present study was a cross-sectional and descriptive study. The study’s statistical population included all patients referred to the infectious disease ward of Imam Khomeini Hospital due to urinary tract infections during the project period. Urine samples were collected in sterile containers, and by using a calibrated loop, the urine sample was cultured on EMB and blood agar media under sterile conditions. Microbial sensitivity was performed by standard disk diffusion method, and the results were analyzed using SPSS-V 16 software.

Results

The antibiotic resistance assays showed that the highest resistance included nalidixic acid (73.5%), ciprofloxacin (72.1%), cotrimoxazole (70.6%), and ceftazidime (61.8%), cefixime (57.4%), ceftriaxone (48.5%), gentamicin (32.4%), cephalothin (16.6%), nitrofurantoin (10.3%), norfloxacin (5.9%), cefotaxime (4.4%), imipenem (2.9%), cefepime (2.9%), ampicillin (2.9%), ceftizoxime (1.5%), vancomycin (1.5%), cefazolin (1.5%), and chloramphenicol (1.5%), respectively. In addition, investigating the antibiotic resistance of UTI-causing bacteria according to the gender and age of the patients in the present study showed no significant statistical difference (P > 0.05).

Conclusion

The bacteria causing urinary infections in the study area mainly belonged to the E. coli and Klebsiella families. Considering the determination of antibiotic sensitivity patterns in common organisms in the studied area, its report to doctors can be considered in experimental treatments.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
UTI
Urinary tract infection
E. coli
Escherichia coli

1 Background

Urinary tract infections (UTIs) are humans’ most common bacterial infections, occurring in all age groups [1]. Lack of proper diagnosis and timely treatment can cause severe complications, such as urinary tract disorders, scars remaining in the kidney parenchyma, blood pressure, and uremia, and in pregnant women, they cause premature birth and even miscarriage [2]. Urinary tract infections, including cystitis and pyelonephritis, are common in the hospital. Among the pathogens that cause urinary infections, E. coli is the dominant pathogen that causes nearly 80% of infections and infects 8–10 million people in the USA annually [3, 4].
Based on the statistics of international organizations, 17–29 billion dollars are spent annually on the treating hospital infections, of which 39% are related to the costs caused by urinary infections [4]. Gram-negative bacilli are the most common etiological factor of UTI; among them, E. coli accounts for more than 80% of acute urinary tract infections [5]. Staphylococcus saprophyticus is the cause of 5–10% of urinary infections; other bacterial causes include Klebsiella, Proteus, Pseudomonas, and Enterobacter. These cases are not very common and are usually related to urinary system abnormalities or urinary catheters [5, 6].
Infectious diseases are always considered a serious threat to health. With the discovery of antibiotics, the death caused by infectious diseases has decreased significantly. However, these diseases are returning due to the uncontrolled use of antibiotics and resistance to them. Owing to the increase in resistance to antibiotics, the world urgently needs to change the pattern of consumption and prescription of this valuable medicinal source [7, 8]. If the consumption of medicines remains with the same pattern, even the production and development of new medicines cannot prevent the increase of resistance to antibiotics. In addition to the lack of uncontrolled use of antibiotics, measures to reduce the spread of infection through regular vaccination, regular hand washing, and paying attention to food hygiene are necessary [9]. It should be noted that antibiotics can only treat bacterial infections and are ineffective against viral infections such as colds, sore throats, and influenza.
In other words, it can be stated that antibiotics become resistant to these medicines through gene mutation and new generations arise that cannot be combated [10]. One of the most important factors of this type of medicine resistance is the uncontrolled and excessive use of antibiotics. This phenomenon endangers human society, so its danger has been likened to terrorism. These bacteria’s resistance to antibiotics is one of the biggest challenges that threaten the health of humans in the modern era [11, 12].
Nowadays, the treating these types of infections has faced severe problems due to the increasing use of antibiotics and the subsequent increase in antibiotic resistance. The basis for treating urinary infections is selecting a highly efficient and effective antibiotic [13]. Antibiotics that were once effective now have minimal effect on bacteria that cause urinary tract infections, primarily due to the emergence and spread of bacteria-resistant strains, population growth, travel, and uncontrolled and excessive use of antibiotics [11, 12, 14]. Different studies suggest that regardless of the pattern of antibiotic consumption, antibiotic-resistance genes can be transferred among bacterial populations [14]. Urinary tract infections are more common in females than males. Around half of all females experience at least one infection during their lifetime, and recurrences are common [1517].
Changing the sensitivity pattern of bacteria to different antibiotics over time and in different geographical areas has become a serious problem. Hence, antibiotic treatment of infections should be based on the information obtained from the antibiotic sensitivity and resistance pattern. Due to the increasing use of antibiotics and the subsequent increase in antibiotic resistance, as well as the differences in antibiotic sensitivity in dealing with different bacteria, recognizing the sensitivity pattern of this organism to antibiotics can be helpful in the treatment of most patients suffering from a urinary tract infection [1820]. The present study aims to evaluate the antibiotic resistance pattern of UTI-causing bacteria in urine culture samples of infectious ward patients of Imam Khomeini Hospital in Kermanshah between 2016 and 2018.

2 Methods

2.1 Study locations and ethical approval

The present study was a cross-sectional and descriptive study. After obtaining the consent form from all patients, the study’s statistical population included all patients referred to the infectious disease ward of Imam Khomeini Hospital due to urinary tract infections during the project period. Based on the study by Mahmoudi et al. [21], E. coli isolates in urinary infection samples have the highest resistance to co-trimoxazole antibiotics (74%). Based on 74% resistance, the minimum sample volume formula and 95% confidence, and the error of 0.1, the minimum sample size is 74 people. The code of ethics (IR.KUMS.REC.1398.191) was received from the Kermanshah University of Medical Sciences after obtaining permission from the research assistant. Inclusion criteria were catheterized patients with a final diagnosis of urinary tract infection, no history of hospitalization and catheterization, and no antibiotic use for two weeks before sending their samples to the laboratory. In addition, patients who consumed antibiotics during sampling or one month after hospitalization were excluded from this research.

2.2 Sample collections and culture procedure

For the final diagnosis of urinary tract infection, midstream urine samples were collected in sterile containers and using a calibrated loop (0.01 ml). The midstream urine sample was cultured on EMB and blood agar media under sterile conditions incubated at 37 °C. After 18–24 h, the samples in which the number of grown colonies was equal to or more than 100,000 CUF/ml were considered positive regarding urinary infection. To identify the bacteria, biochemical tests and differential culture media such as indole production and motility (sulfide indole motility: SIM), triple sugar iron agar (TSI), urease, methyl red (methyl red), Voges–Proskauer, lysine decarboxylase (LD) were used.

2.3 Antibiotic susceptibility test

Antibiotic resistance tests were performed using 11 antibiotic disks, including ceftazidime (30 μg), cefotaxime (30 μg), imipenem (10 μg), cefixime (5 μg), nitrofurantoin (300 μg), cotrimoxazole (25 μg), nalidixic acid (30 μg), ciprofloxacin (5 μg), gentamicin (10 μg), ampicillin (25 μg), and cefoxitin (30 μg) [16]. The sample was placed on a plate and incubated at 37 °C. After 24 h, the inhibition zone diameter was measured and used to determine antibiotic susceptibility (i.e., susceptible or resistant) for each microorganism, according to CLSI guidelines [15]. A checklist was completed based on demographic and laboratory information to identify the bacteria that cause urinary tract infections and their antibiotic resistance, which is available in the laboratory of Imam Khomeini Hospital, by the project executor.

2.4 Statistical analysis

Data were performed using Microsoft Office Excel 2013, SPSS version 16 (Statistical Package for Social Sciences). The Chi-square or Fisher’s exact test was performed to investigate the significance of the differences. A p-value of less than 0.05 was considered statistically significant.

3 Results

Seventy-four patients with urinary tract infections referred to the infectious ward of Imam Khomeini Hospital were studied. The following sections deliberately describe each phase using the data from these patients.

3.1 Identifying the frequency of bacteria causing urinary infection

After carrying out bacterial cultures, eight different bacteria species were identified from the urine sample with significant growth. The most common bacterium causing urinary tract infections in patients was E. coli (58.82%), followed by Klebsiella (19.12%), Acinetobacter (11.76%), Staphylococcus aureus (2.95%), and Pseudomonas (2.94%). Staphylococcus epidermidis (1.47%), Pseudomonas aeruginosa (1.47%), and Staphylococcus auricularis (1.47%) which were the least frequent isolates in this population, as shown in Fig. 1.

3.2 Identifying the frequency of used antibiotics

Based on the results of this study, the most common antibiotics used in the studied patients were nalidixic acid (73.53%), ciprofloxacin (72.06%), cefixime (72.05%), and cotrimoxazole (70.59%), ceftazidime (61.76%), ceftriaxone (61.76%), amikacin (33.82%), imipenem (27.94%), gentamicin (32.35%), cephalothin (16.18%), and vancomycin (14.7%), respectively, as shown in Table 1.
Table 1
Number and frequency percentage of antibiotics used in the studied patients
Consumed antibiotics
Number
f (%)
Norfloxacin
  
 Consumed
4
88.5
 Not consumed
64
12.94
Imipenem
  
 Consumed
19
27.94
 Not consumed
49
72.06
Vancomycin
  
 Consumed
10
14.71
 Not consumed
58
58.29
Rifampin
  
 Consumed
2
2.94
 Not consumed
66
97.06
Metronidazole
  
 Consumed
4
5.88
 Not consumed
64
94.12
Tazocin
  
 Consumed
3
4.41
 Not consumed
65
95.59
Clindamycin
  
 Consumed
3
4.41
 Not consumed
65
95.59
Amikacin
  
 Consumed
23
33.82
 Not consumed
45
66.18
Nitrofurantoin
  
 Consumed
0
0
 Not consumed
68
100
Co-trimoxazole
  
 Consumed
48
70.59
 Not consumed
20
29.41
Norfloxacin
  
 Consumed
4
5.88
 Not consumed
5.88
94.12
Cefotaxime
  
 Consumed
3
4.41
 Not consumed
65
95.59
Streptomycin
  
 Consumed
1
1.47
 Not consumed
67
98.53
Ampibactam
  
 Consumed
3
4.41
 Not consumed
65
65.59
Azithromycin
  
 Consumed
4
5.88
 Not consumed
64
94.12
Isoniazid
  
 Consumed
1
1.47
 Not consumed
67
98.53
Chloramphenicol
  
 Consumed
1
1.47
 Not consumed
67
98.53
Tetracycline
  
 Consumed
0
0
 Not consumed
68
100
Ofloxacin
  
 Consumed
0
0
 Not consumed
68
100
Cefazolin
  
 Consumed
1
1.47
 Not consumed
67
98.53
Nalidixic acid
  
 Consumed
50
73.53
 Not consumed
18
26.47
Cephalothin
  
 Consumed
11
16.18
 Not consumed
57
83.82
Cefepime
  
 Consumed
2
2.94
 Not consumed
66
97.06
Tobramycin
  
 Consumed
0
0
 Not consumed
68
68(100)
Amoxicillin
  
 Consumed
0
0
 Not consumed
68
100
Ceftriaxone
  
 Consumed
42
61.76
 Not consumed
26
38.24
Cefixime
  
 Consumed
49
72.05
 Not consumed
19
27.95
Ceftazidime
  
 Consumed
42
61.76
 Not consumed
26
38.24
Ceftizoxime
  
 Consumed
1
1.49
 Not consumed
67
98.53
Nitrofurantoin
  
 Consumed
7
10.29
 Not consumed
61
89.71
Ciprofloxacin
  
 Consumed
49
72.06
 Not consumed
19
27.94
Gentamicin
  
 Consumed
22
32.35
 Not consumed
46
67.65
Ampicillin
  
 Consumed
2
2.94
 Not consumed
66
97.06

3.3 Identifying the frequency of UTI-causing bacteria based on age

Patients were divided into six age groups: ≤ 30 years, 31–40 years, 41–50 years, 51–60 years, 61–70 years, and ≥ 71 years (Table 2). Accordingly, in Table 2, the urinary infection with the bacterial agent E. coli was more (40%) in the ≥ 71 age group and the lowest in the 41–50 age group (2.5%). Klebsiella bacterial agent was seen in all age groups except ≤ 30. The bacterial agent Acinetobacter was seen in age groups ≥ 41. The bacterial agent Staphylococcus aureus was seen only in two age groups ≥ 71 and ≤ 30. Bacterial agents Staphylococcus epidermidis, Pseudomonas aeruginosa, and Staphylococcus auricularis were seen in the age groups 61–70, 51–60, and ≤ 30, respectively. In contrast, the bacterial agent Pseudomonas was seen only in groups 51–60 and those ≥ 71.
Table 2
Number and percentage of frequency of bacteria causing urinary infection based on the age of the studied patients
Bacteria
Less than 30
31–40
41–50
51–60
61–70
More than 71
n
(%) f
n
(%)f
n
(%) f
n
(%) f
n
(%) f
n
(%) f
E. coli
5
12.5
5
2
1
2.5
8
20
8
20
16
40
Klebsiella
0
0
1
7.7
1
7.7
4
30.8
3
23.1
4
30.8
Acinetobacter
0
0
0
0
2
25
2
25
2
25
2
25
Staphylococcus aureus
1
50
0
0
0
0
0
0
0
0
1
50
Staphylococcus epidermidis
0
0
0
0
0
0
0
0
1
100
0
0
Pseudomonas aeruginosa
0
0
0
0
0
0
1
100
0
0
0
0
Pseudomonas
0
0
0
0
0
0
1
50
0
0
1
50
Staphylococcus auricularis
1
100
0
0
0
0
0
0
0
0
0
0

3.4 Identifying the frequency of UTI-causing bacteria based on gender

Table 3 shows the frequency of UTI-causing bacteria according to gender. E. coli showed a higher percentage of urinary tract infections in females (55%) than in males (45%). Meanwhile, UTIs caused by Klebsiella bacteria were 64.5% and 35.5% in women and men, respectively. In addition, UTIs caused by the bacterial agent Acinetobacter were 62.5 and 37.5% in women and men, respectively. The prevalence of UTI caused by Staphylococcus aureus and Pseudomonas bacteria was the same (50%) in both sexes. In contrast, the prevalence of UTI caused by Staphylococcus epidermidis and Staphylococcus auricularis bacteria was seen only in the female population, and Pseudomonas aeruginosa bacteria were seen only in the male population.
Table 3
Number and frequency percentage of UTI-causing bacteria based on gender in the studied patients
Bacteria
Female
Male
n
(%) f
n
(%) f
E. coli
22
55
18
45
Klebsiella
6
64.5
3
35.5
Acinetobacter
5
62.5
3
37.5
Staphylococcus aureus
1
50
1
50
Staphylococcus epidermidis
1
100
0
0
Pseudomonas aeruginosa
0
0
1
100
Pseudomonas
1
50
1
50
Staphylococcus auricularis
1
100
0
0

3.5 Antibiotic resistance of UTI-causing bacteria

Antibiotic resistance test of bacteria causing urinary tract infections showed that the highest resistance was related to ciprofloxacin (72.1%), nalidixic acid (73.5%), and cotrimoxazole (70.6%). On the other hand, the lowest antibiotic resistance of the bacteria responsible for urinary tract infections was related to vancomycin (1.5%), ceftizoxime (1.5%), cefazolin (1.5%), and chloramphenicol (1.5%) as mentioned in Table 4.
Table 4
Number and frequency percentage of antibiotic resistance of UTI-causing bacteria in the studied patients
Antibiotic
Antibiotic resistance
n
(%) f
Amikacin
2
13
Cefixime
4
57
Ceftazidime
8
61
Ceftizoxime
5
1
Nitrofurantoin
3
10
Ciprofloxacin
1
72
Gentamicin
4
32
Cotrimoxazole
6
70
Nalidixic acid
5
73
Norfloxacin
9
5
Cefotaxime
4
4
Cephalothin
6
16
Imipenem
9
2
Vancomycin
5
1
Cefazolin
5
1
Cefepime
9
2
Ampicillin
9
2
Chloramphenicol
5
1
Ceftriaxone
2
48

3.6 Identifying the frequency of antibiotic resistance of UTI-causing bacteria based on the age

As seen in Table 5, ciprofloxacin showed the highest resistance among all antibiotics in the age group of 61–70. While rifampin, metronidazole, tazocin, clindamycin, and isoniazid antibiotics did not cause resistance in any age group. Based on the results of the present study, no statistically significant difference was observed in terms of antibiotic resistance of UTI-causing bacteria based on the age of the patients (P > 0.05).
Table 5
Number and frequency percentage of antibiotic resistance of UTI-causing bacteria based on age
Antibiotic
Less than 30
31–40
41–50
51–60
61–70
More than 71
P-Value
n
(%) f
n
(%) f
n
(%) f
n
(%) f
n
(%) f
n
(%) f
Amikacin
             
 Resistant
0
0
0
0
0
0
2
12.5
3
21.43
4
16.67
0.018
 Not-resistant
7
100
3
100
4
100
14
87.5
11
87.57
20
83.33
 
Cefixime
             
 Resistant
5
71.43
2
66.67
2
50
10
62.5
8
57.14
12
50
0.654
 Not-resistant
2
28.57
1
33.33
2
50
6
37.5
6
42.86
12
50
 
Ceftazidime
             
 Resistant
2
28.57
2
66.67
3
75
11
68.75
11
87.75
13
54.17
0.654
 Not-resistant
5
71.43
1
33.33
1
25
5
31.25
3
21.43
11
45.73
 
Ceftizoxime
             
 Resistant
1
14.29
0
0
0
0
0
0
0
0
0
0
 Not-resistant
6
85.71
3
100
4
100
16
100
14
100
24
100
 
Nitrofurantoin
             
 Resistant
0
0
1
33.33
0
0
2
12.5
1
7.14
3
12.5
 Not-resistant
7
100
2
66.67
4
100
14
87.5
13
92.86
21
87.5
 
Ciprofloxacin
             
 Resistant
3
42.86
1
33.33
0
0
10
62.5
13
92.86
18
75
 
 Not-resistant
4
57.14
2
66.67
4
100
6
37.5
1
7.14
6
25
0.069
Gentamicin
             
 Resistant
1
14.29
0
0
1
25
6
37.5
7
50
7
29.17
 
 Not-resistant
6
85.71
3
100
3
75
10
62.5
7
50
17
70.83
0.577
Cotrimoxazole
             
 Resistant
5
71.43
0
0
1
25
13
81.25
9
64.29
17
70.83
0.115
 Not-resistant
2
28.27
3
100
3
75
3
18.75
5
35.71
7
29.17
 
Nalidixic acid
             
 Resistant
4
57.14
0
0
3
75
13
81.25
11
78.57
16
66.67
 
 Not-resistant
3
42.86
3
100
1
25
3
18.75
3
21.43
8
33.33
Norfloxacin
            
 Resistant
2
28.27
0
0
0
0
1
6.25
1
7.14
0
0
 
 Not-resistant
5
71.43
3
100
4
100
15
93.75
13
92.86
24
100
 
Cefotaxime
             
 Resistant
1
14.29
0
0
0
0
1
6.25
1
7.14
0
0
 Not-resistant
6
85.71
3
100
4
100
15
93.75
13
92.86
24
100
 
Cephalothin
            
 Resistant
2
28.57
0
0
0
0
3
18.75
3
21.45
3
12.5
 
 Not-resistant
5
71.43
3
100
4
100
13
81.25
11
87.57
21
87.5
 
Imipenem
             
 Resistant
0
0
0
0
0
0
0
0
0
0
2
8.33
0.143
 Not-resistant
7
100
3
100
4
100
16
100
14
100
22
91.67
 
Vancomycin
             
 Resistant
1
14.29
0
0
0
0
0
0
0
0
0
0
0.932
 Not-resistant
6
85.71
3
100
4
100
16
100
14
100
24
100
 
Rifampin
             
 Resistant
0
0
0
0
0
0
0
0
0
0
0
0
0.903
 Not-resistant
7
100
3
100
4
100
16
100
14
100
24
100
 
Metronidazole
             
 Resistant
0
0
0
0
0
0
0
0
0
0
0
0
0.781
 Not-resistant
7
100
3
100
4
100
16
100
14
100
24
100
 
Tazocin
             
 Resistant
0
0
0
0
0
0
0
0
0
0
0
0
0.219
 Not-resistant
7
100
3
100
4
100
16
100
14
100
24
100
 
Clindamycin
             
 Resistant
0
0
0
0
0
0
0
0
0
0
0
0
0.482
 Not-resistant
7
100
3
100
4
100
16
100
14
100
24
100
 
Cefazolin
             
 Resistant
0
0
0
0
0
0
0
0
1
7.14
0
0
 Not-resistant
7
100
3
100
4
100
16
100
13
92.86
24
100
 
Cefepime
             
 Resistant
0
0
0
0
0
0
0
0
1
7.14
1
4.17
0.562
 Not-resistant
7
100
3
100
4
100
16
100
13
92.86
23
95.83
 
Isoniazid
             
 Resistant
0
0
0
0
0
0
0
0
0
0
0
0
0.654
 Not-resistant
7
100
3
100
4
100
16
100
14
100
24
100
 
Ampicillin
             
 Resistant
0
0
0
0
0
0
0
0
2
14.29
0
0
0.868
 Not-resistant
7
100
3
100
4
100
16
100
12
85.71
24
100
 
Chloramphenicol
             
 Resistant
0
0
0
0
0
0
0
0
0
0
1
4.17
 Not-resistant
7
100
3
100
4
100
16
100
14
100
23
95.83
 
Ceftriaxone
             
 Resistant
3
42.86
2
66.67
2
50
8
50
8
57.14
10
41.67
0.083
 Not-resistant
4
57.14
1
33.33
2
50
8
50
6
42.86
14
58.33
 

3.7 Identifying the frequency of antibiotic resistance of UTI-causing bacteria based on gender

Table 6 shows that men’s antibiotic resistance was related to nalidixic acid (73.14%) and ceftazidime (67.74%). Cotrimoxazole (78.39%) and nalidixic acid (72.97%) antibiotics had the highest resistance in women. Based on the results of the present study, no statistically significant difference was observed in terms of antibiotic resistance of UTI-causing bacteria found on the gender of the patients (P > 0.05). Only more antibiotic resistance to gentamicin was reported as significant in males than in females (P = 0.039).
Table 6
Number and frequency percentage of antibiotic resistance of UTI-causing bacteria based on the gender
Antibiotic
Female
Male
P-Value
n
(%) f
n
(%) f
Amikacin
     
 Resistant
3
8.11
6
19.35
0.173
 Not-resistant
34
94.89
25
80.65
 
Cefixime
     
 Resistant
21
56.76
18
58.06
0.914
 Not-resistant
16
43.24
13
41.94
 
Ceftazidime
    
0.353
 Resistant
21
56.76
21
67.74
 
 Not-resistant
16
43.24
10
32.26
 
Ceftizoxime
     
 Resistant
1
2.7
0
0
0.364
 Not-resistant
36
97.30
31
100
 
Nitrofurantoin
     
 Resistant
4
10.18
3
9.68
0.876
 Not-resistant
33
89.19
28
90.32
 
Ciprofloxacin
     
 Resistant
23
62.16
3
9.68
0.878
 Not-resistant
14
37.84
28
90.32
 
Gentamicin
     
 Resistant
8
21.62
14
45.16
0.039
 Not-resistant
29
78.38
17
54.74
 
Cotrimoxazole
     
 Resistant
29
78.39
19
61.29
0.123
 Not-resistant
8
21.62
12
38.71
 
Nalidixic acid
     
 Resistant
27
72.97
23
73.14
0.910
 Not-resistant
10
10.03
8
25.81
 
Norfloxacin
     
 Resistant
2
5.14
2
6.45
0.855
 Not-resistant
35
94.59
29
93.55
 
Cefotaxime
     
 Resistant
2
5.14
1
3.25
0.663
 Not-resistant
35
94.59
30
96.77
 
Cephalothin
     
 Resistant
4
10.81
7
22.58
0.189
 Not-resistant
33
83.19
24
77.42
 
Imipenem
     
 Resistant
1
2.70
1
3.23
0.899
 Not-resistant
36
96.30
30
96.77
 
Vancomycin
     
 Resistant
1
2.70
0
0
0.356
 Not-resistant
36
96.30
31
100
 
Rifampin
     
 Resistant
0
0
0
0
 Not-resistant
37
100
31
100
 
Metronidazole
     
 Resistant
0
0
0
0
 Not-resistant
37
100
31
100
 
Tazocin
     
 Resistant
0
0
0
0
-
 Not-resistant
37
100
31
100
 
Clindamycin
     
 Resistant
0
0
0
0
 Not-resistant
37
100
31
100
 
Cefazolin
     
 Resistant
1
2.70
0
0
0.356
 Not-resistant
36
96.30
31
100
 
Cefepime
     
 Resistant
2
5.14
0
0
0.189
 Not-resistant
35
94.59
31
100
 
Isoniazid
     
 Resistant
0
0
0
0
 Not-resistant
37
100
31
100
 
Ampicillin
     
 Resistant
2
5.14
0
0
0.189
 Not-resistant
35
94.59
31
100
 
Chloramphenicol
     
 Resistant
0
0
1
3.23
0.271
 Not-resistant
37
100
30
96.77
 
Ceftriaxone
     
 Resistant
18
48.65
15
48.39
0.983
 Not-resistant
19
51.35
15
51.61
 

4 Discussion

The incidence of antibiotic resistance is increasing dramatically worldwide. UTI, which affects numerous individuals yearly, is an infectious illness generated by bacteria with various antibiotic resistance patterns [22]. On the other hand, the increasing spread of antibiotic resistance causes additional treatment costs, hospitalizations, and more deaths [23]. Considering that many studies have not been conducted to evaluate the results of antibiotic resistance treatment in pathogens in the western region of Iran, the present study was conducted to investigate the effects and clinical consequences of antibiotic resistance in urinary pathogens in patients with UTI. This study was conducted on 74 patients diagnosed with urinary tract infection (UTI)-causing bacteria in the urine culture samples admitted to Imam Khomeini Hospital in Kermanshah between 2016 and 2018.
The results of the present study also showed that E. coli and Klebsiella, in general, were the most common causes of urinary tract infections, consistent with other studies [24]. These findings were in line with the studies of other researchers in this field [25, 26]. In addition, consistent with our results, Motamedifar et al. [27] reported that E. coli was the most common cause of UTI, followed by Klebsiella species. Farajnia et al. [28] showed that E. coli, P. aeruginosa, and Staphylococcus saprophyticus bacteria are the most common causes of UTI in patients under 9 nine years and older. Meanwhile, in our study, E. coli bacteria caused the most common causes of UTI in people over 71 years of age, and it did not match our results. According to the reports of other researchers, such as Raya et al. [29], Vazuras et al. [30], and Duicu et al. [31], in this field, E. coli was the leading cause of UTI in our study. Therefore, the role of E. coli in causing UTIs has been presented in many researchers’ reports [32]. These changes depend on various factors such as geographic region, people’s race, type of pollution, etc. [33].
In our study, E. coli bacteria were the leading cause of UTI in 16 people (40%) in the age group ≥ 71. However, in reporting the results of our data, the patterns of UTIs caused by other bacterial agents other than E. coli were not the same in different age groups. On the other hand, apart from the type of bacteria causing UTI, no statistically significant difference was seen among people in different age groups. The report of the study by Shasharkinia et al. indicated that statistically, there was a significant relationship between the type of bacteria that causes UTI and the age of people, in which the main cause of UTI in all ages is E. coli (75%) followed by Proteus (11%) which was not consistent with the results of our study [34].
Complete treatment of UTI in patients occurs when the infection’s bacterial cause and the antibiotic sensitivity patterns are diagnosed in time [35]. By comparing the reports of several studies on the resistance of different antibiotics in Iran and other countries, it was observed that the resistance of different antibiotics to urinary pathogens in Iran and other countries is a cause of great concern for treating UTI patients [36]. In the present study, the antibiotic resistance of different bacteria differed; each was resistant to some antibiotics and sensitive to others. Molazade et al. [37] reported that the most common organisms were E. coli at 64.3%, Klebsiella at 14.5%, and Staphylococcus at 6.4%. Bacteria had the highest sensitivity to ciprofloxacin and nitrofurantoin and had the highest resistance to co-trimoxazole and cephalothin antibiotics. In this regard, in our study, the highest resistance belonged to nalidixic acid (73.5%), ciprofloxacin (72.1%), and cotrimoxazole (70.6%), ceftazidime (61.8%), cefixime (57.4%), and ceftriaxone (48.5%), respectively. In the study conducted by Molazade et al., it was recommended to use ciprofloxacin and nitrofurantoin in cases where it is necessary to treat urinary tract infections in an outpatient way. The selection of antibiotics for treating urinary tract infections should be based on the prevalence of bacteria in each region and their sensitivity to the desired antibiotic.
In line with the results of the present study, which shows that women are more likely to suffer from urinary tract infections than men, in the study of Haqgoo et al. [38], 72.3% of patients with positive urine culture were women and 27.7% were men. In the study of Jarsiah et al. [39], it was also observed that the number of positive cultures is more in women than in men. In the study of Ramezanzadeh et al. [40], most of the bacteria were also isolated from women’s samples. It was also reported in Laupland et al. [41] study that the rate of urinary infection was higher in women. The present study’s findings are supported by all of the mentioned results, which suggest that women may be more susceptible to this condition because of their shorter urethra and the proximity of its outlet to the vagina and anus.
Majumder et al. reported that the main cause of UTI in their study population was E.coli bacteria (75%), followed by Klebsiella (10.7%) and Enterococcus (6%). Most (73.3%) of antibiotic resistance in this study were female, and this gender difference was statistically significant. The most potent antibiotics in this study were imipenem, meropenem, amikacin, and nitrofurantoin. The effectiveness of these drugs was 91–100%. Over 60% antibiotic resistance against amoxicillin, nalidixic acid, cefixime, ciprofloxacin, co-trimoxazole, and cephalosporins was reported [42], which is consistent with the findings of our study to some extent.
In the present study, most bacterial resistance to antibiotics was seen in the age groups of 31–40 and 41–50. The reason for this can be that these ages are more sexually active. These results are more or less consistent with other studies [43]. Including, in the study of Haqgou et al., the average age of patients with positive urine culture was 61.0 ± 18.6 years, which is not consistent with the results of the present study [38].
In a study carried out by Asadpour et al. [13] to identify the pattern of antibiotic resistance of E. coli in the urine samples of patients, 980 urine samples were examined. Of the 195 E. coli isolates, 93.76% were from females, while the remaining were from males. The highest sensitivity was obtained for imipenem. The highest level of resistance in the penicillin family belonged to oxacillin and ampicillin, and in the cephalosporins family, the highest level belonged to cephalothin. Also, the lowest resistance to cefoxitin was obtained. Among the quinolones, the highest resistance was reported for nalidixic acid. Also, the lowest resistance was reported for gentamicin, nitrofurantoin, and cefoxitin, with 8.2%, 8.71%, and 11.79%, respectively. Also, 36.92% of the strains produced ESBL [13]. In another study by Razak et al. [44], 573 urine samples were examined with the diagnosis of urinary tract infection. E. coli was the most common pathogen (37.95%), followed by Klebsiella (21.41%) and Acinetobacter (10.94%), respectively. E. coli was very sensitive to antibiotics nitrofurantoin (81.92%) and amikacin (69.88%) and was very resistant to ampicillin. Klebsiella was very sensitive to imipenem and was reportedly to be very resistant to ampicillin [44], which was consistent with the results of our study.
Overall, the present study’s general results are consistent with previous studies’ results. Despite this, the amount of drug resistance to all kinds of antibiotics in other regions of the world due to genetic changes in the strains that cause resistance, differences in the amount of antibiotic consumption, arbitrary use of antibiotics, differences in the availability of antibiotics, the extent and the new, temporal, spatial, cultural, and health conditions of the studied communities have been different [40]. In addition, the reasons for the observed differences have been previously mentioned. Other factors that may contribute to discrepancies in study results include variations in patient population characteristics, differences in hospitalization conditions and ward types, and variations in the method of drug administration (e.g., oral versus injection).

5 Conclusions

Based on the results of the present study, the most common bacteria causing urinary tract infections were E. coli and Klebsiella. The probability of a positive urine culture result was higher in women than in men. The incidence of urinary tract infections (UTIs) is positively correlated with age, as older individuals are more susceptible to developing these infections. Given the considerable antibiotic resistance demonstrated by bacteria responsible for urinary tract infections in both the present study and recent research, it is recommended that clinicians take this issue into account when devising treatment strategies for affected patients. Moreover, considering the increasing prevalence of antibiotic resistance globally and in Iran, planning and training for correctly using antibiotics in necessary cases and in the correct manner are recommended. In order to better and more accurately investigate the pattern of antibiotic resistance in the province of Kermanshah in Iran, it is suggested to conduct more comprehensive studies with a larger number of samples in different cities of the province and different hospitals.

Acknowledgements

All the authors are grateful to all the Imam Khomeini Kermanshah Hospital staff for their help and cooperation.

Declarations

All precipitants signed a written consent form. Also, the study protocol was approved by the local ethics committee of Kermanshah University of Medical Sciences (IR.KUMS.REC.1398.191).
Not applicable.

Competing interests

So far, no conflicts of interest have been reported between the authors.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Urologie

Kombi-Abonnement

Mit e.Med Urologie erhalten Sie Zugang zu den urologischen CME-Fortbildungen und Premium-Inhalten der urologischen Fachzeitschriften.

Literatur
1.
2.
Zurück zum Zitat Uwaezuoke SN, Ndu IK, Eze IC (2019) The prevalence and risk of urinary tract infection in malnourished children: a systematic review and meta-analysis. BMC Pediatr 19(1):1–20CrossRef Uwaezuoke SN, Ndu IK, Eze IC (2019) The prevalence and risk of urinary tract infection in malnourished children: a systematic review and meta-analysis. BMC Pediatr 19(1):1–20CrossRef
4.
Zurück zum Zitat Foxman B (2003) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 49(2):53–70CrossRefPubMed Foxman B (2003) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 49(2):53–70CrossRefPubMed
5.
Zurück zum Zitat Agency EM (2011) Trends in the sales of veterinary antimicrobial agents in nine European countries (2005–2009). European Medicines Agency, London Agency EM (2011) Trends in the sales of veterinary antimicrobial agents in nine European countries (2005–2009). European Medicines Agency, London
6.
Zurück zum Zitat Behzadi P, Behzadi E, Ranjbar R (2015) Urinary tract infections and Candida albicans. Central European J Urol 68(1):96–101 Behzadi P, Behzadi E, Ranjbar R (2015) Urinary tract infections and Candida albicans. Central European J Urol 68(1):96–101
7.
Zurück zum Zitat Organization WH (2001) WHO global strategy for containment of antimicrobial resistance. World Health Organization Organization WH (2001) WHO global strategy for containment of antimicrobial resistance. World Health Organization
8.
Zurück zum Zitat Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ (2015) Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13(5):269–284CrossRefPubMedPubMedCentral Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ (2015) Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13(5):269–284CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Mortazavi F, Shahin N (2009) Changing patterns in sensitivity of bacterial uropathogens to antibiotics in children. Pak J Med Sci 25(5):801–805 Mortazavi F, Shahin N (2009) Changing patterns in sensitivity of bacterial uropathogens to antibiotics in children. Pak J Med Sci 25(5):801–805
10.
Zurück zum Zitat Kibret M, Abera B (2011) Antimicrobial susceptibility patterns of E. coli from clinical sources in northeast Ethiopia. African Health Sci 11:40–5 Kibret M, Abera B (2011) Antimicrobial susceptibility patterns of E. coli from clinical sources in northeast Ethiopia. African Health Sci 11:40–5
11.
Zurück zum Zitat Raj JRM, Vittal R, Shivakumaraswamy SK, Deekshit VK, Chakraborty A, Karunasagar I (2019) Presence & mobility of antimicrobial resistance in Gram-negative bacteria from environmental samples in coastal Karnataka, India. Indian J Med Res 149(2):290CrossRef Raj JRM, Vittal R, Shivakumaraswamy SK, Deekshit VK, Chakraborty A, Karunasagar I (2019) Presence & mobility of antimicrobial resistance in Gram-negative bacteria from environmental samples in coastal Karnataka, India. Indian J Med Res 149(2):290CrossRef
13.
Zurück zum Zitat Asadpour Rahimabadi K, Hashemitabar G, Mojtahedi A (2016) Antibiotic-resistance patterns in E. coli isolated from patients with urinary tract infection in Rasht. J Guilan Univ of Med Sci 24(96):22–9 Asadpour Rahimabadi K, Hashemitabar G, Mojtahedi A (2016) Antibiotic-resistance patterns in E. coli isolated from patients with urinary tract infection in Rasht. J Guilan Univ of Med Sci 24(96):22–9
14.
Zurück zum Zitat Hejazi F, Ahanjan M, Akha O, Salehiyan M (2018) Phenotypic study of urinary tract infection producing bacteria and antibiotic resistance pattern in diabetic patients. J Mazandaran Univ Med Sci 28(163):38–46 Hejazi F, Ahanjan M, Akha O, Salehiyan M (2018) Phenotypic study of urinary tract infection producing bacteria and antibiotic resistance pattern in diabetic patients. J Mazandaran Univ Med Sci 28(163):38–46
15.
Zurück zum Zitat Grigoryan L, Trautner BW, Gupta K (2014) Diagnosis and management of urinary tract infections in the outpatient setting: a review. JAMA 312(16):1677–1684CrossRefPubMed Grigoryan L, Trautner BW, Gupta K (2014) Diagnosis and management of urinary tract infections in the outpatient setting: a review. JAMA 312(16):1677–1684CrossRefPubMed
16.
Zurück zum Zitat Momtaz H, Karimian A, Madani M, Safarpoor Dehkordi F, Ranjbar R, Sarshar M et al (2013) Uropathogenic Escherichia coli in Iran: serogroup distributions, virulence factors and antimicrobial resistance properties. Ann Clin Microbiol Antimicrob 12:1–12CrossRef Momtaz H, Karimian A, Madani M, Safarpoor Dehkordi F, Ranjbar R, Sarshar M et al (2013) Uropathogenic Escherichia coli in Iran: serogroup distributions, virulence factors and antimicrobial resistance properties. Ann Clin Microbiol Antimicrob 12:1–12CrossRef
17.
Zurück zum Zitat Niranjan V, Malini A (2014) Antimicrobial resistance pattern in Escherichia coli causing urinary tract infection among inpatients. Indian J Med Res 139(6):945PubMedPubMedCentral Niranjan V, Malini A (2014) Antimicrobial resistance pattern in Escherichia coli causing urinary tract infection among inpatients. Indian J Med Res 139(6):945PubMedPubMedCentral
18.
Zurück zum Zitat VA ARS, Shenoy S, Yadav T, Radhakrishna M (2013) The antibiotic susceptibility patterns of uropathogenic Escherichia coli, with special reference to the fluoroquinolones. J Clin Diagn Res JCDR 7(6):1027 VA ARS, Shenoy S, Yadav T, Radhakrishna M (2013) The antibiotic susceptibility patterns of uropathogenic Escherichia coli, with special reference to the fluoroquinolones. J Clin Diagn Res JCDR 7(6):1027
19.
Zurück zum Zitat Meddings JA, Reichert H, Rogers MA, Saint S, Stephansky J, McMahon LF Jr (2012) Effect of nonpayment for hospital-acquired, catheter-associated urinary tract infection: a statewide analysis. Ann Intern Med 157(5):305–312CrossRefPubMedPubMedCentral Meddings JA, Reichert H, Rogers MA, Saint S, Stephansky J, McMahon LF Jr (2012) Effect of nonpayment for hospital-acquired, catheter-associated urinary tract infection: a statewide analysis. Ann Intern Med 157(5):305–312CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Razine R, Azzouzi A, Barkat A, Khoudri I, Hassouni F, Charif Chefchaouni A et al (2012) Prevalence of hospital-acquired infections in the university medical center of Rabat. Morocco Int Arch Med 5(1):1–8 Razine R, Azzouzi A, Barkat A, Khoudri I, Hassouni F, Charif Chefchaouni A et al (2012) Prevalence of hospital-acquired infections in the university medical center of Rabat. Morocco Int Arch Med 5(1):1–8
21.
Zurück zum Zitat Mahmoudi H, Alikhani MY, Arabestani M, Khosravi S (2014) Evaluation prevalence agents of urinary tract infection and antibiotic resistance in patients admitted to hospitals in Hamadan university of medical sciences 1391–92. Pajouhan Scientific Journal 12(3):20–27 Mahmoudi H, Alikhani MY, Arabestani M, Khosravi S (2014) Evaluation prevalence agents of urinary tract infection and antibiotic resistance in patients admitted to hospitals in Hamadan university of medical sciences 1391–92. Pajouhan Scientific Journal 12(3):20–27
22.
Zurück zum Zitat Schwartz DJ, Conover MS, Hannan TJ, Hultgren SJ (2015) Uropathogenic Escherichia coli superinfection enhances the severity of mouse bladder infection. PLoS Pathog 11(1):e1004599CrossRefPubMedPubMedCentral Schwartz DJ, Conover MS, Hannan TJ, Hultgren SJ (2015) Uropathogenic Escherichia coli superinfection enhances the severity of mouse bladder infection. PLoS Pathog 11(1):e1004599CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Bidell MR, Opraseuth MP, Yoon M, Mohr J, Lodise TP (2017) Effect of prior receipt of antibiotics on the pathogen distribution and antibiotic resistance profile of key Gram-negative pathogens among patients with hospital-onset urinary tract infections. BMC Infect Dis 17(1):1–7CrossRef Bidell MR, Opraseuth MP, Yoon M, Mohr J, Lodise TP (2017) Effect of prior receipt of antibiotics on the pathogen distribution and antibiotic resistance profile of key Gram-negative pathogens among patients with hospital-onset urinary tract infections. BMC Infect Dis 17(1):1–7CrossRef
26.
Zurück zum Zitat Kornfält Isberg H, Melander E, Hedin K, Mölstad S, Beckman A (2019) Uncomplicated urinary tract infections in Swedish primary care; etiology, resistance and treatment. BMC Infect Dis 19(1):1–8CrossRef Kornfält Isberg H, Melander E, Hedin K, Mölstad S, Beckman A (2019) Uncomplicated urinary tract infections in Swedish primary care; etiology, resistance and treatment. BMC Infect Dis 19(1):1–8CrossRef
27.
Zurück zum Zitat Motamedifar M, Ebrahim-Saraie HS, Mansury D, Khashei R, Hashemizadeh Z, Rajabi A (2016) Antimicrobial susceptibility pattern and age dependent etiology of urinary tract infections in Nemazee Hospital, Shiraz, South-West of Iran. Int J Enteric Pathogens 3(3):1–26931 Motamedifar M, Ebrahim-Saraie HS, Mansury D, Khashei R, Hashemizadeh Z, Rajabi A (2016) Antimicrobial susceptibility pattern and age dependent etiology of urinary tract infections in Nemazee Hospital, Shiraz, South-West of Iran. Int J Enteric Pathogens 3(3):1–26931
28.
Zurück zum Zitat Farajnia S, Alikhani MY, Ghotaslou R, Naghili B, Nakhlband A (2009) Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran. Int J Infect Dis 13(2):140–144CrossRefPubMed Farajnia S, Alikhani MY, Ghotaslou R, Naghili B, Nakhlband A (2009) Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran. Int J Infect Dis 13(2):140–144CrossRefPubMed
29.
Zurück zum Zitat Raya GB, Dhoubhadel BG, Shrestha D, Raya S, Laghu U, Shah A et al (2020) Multidrug-resistant and extended-spectrum beta-lactamase-producing uropathogens in children in Bhaktapur. Nepal Trop Med Health 48:1–7 Raya GB, Dhoubhadel BG, Shrestha D, Raya S, Laghu U, Shah A et al (2020) Multidrug-resistant and extended-spectrum beta-lactamase-producing uropathogens in children in Bhaktapur. Nepal Trop Med Health 48:1–7
30.
Zurück zum Zitat Vazouras K, Velali K, Tassiou I, Anastasiou-Katsiardani A, Athanasopoulou K, Barbouni A et al (2020) Antibiotic treatment and antimicrobial resistance in children with urinary tract infections. J Global Antimicrob Resist 20:4–10CrossRef Vazouras K, Velali K, Tassiou I, Anastasiou-Katsiardani A, Athanasopoulou K, Barbouni A et al (2020) Antibiotic treatment and antimicrobial resistance in children with urinary tract infections. J Global Antimicrob Resist 20:4–10CrossRef
31.
Zurück zum Zitat Duicu C, Cozea I, Delean D, Aldea AA, Aldea C (2021) Antibiotic resistance patterns of urinary tract pathogens in children from central Romania. Exp Ther Med 22(1):1–7CrossRef Duicu C, Cozea I, Delean D, Aldea AA, Aldea C (2021) Antibiotic resistance patterns of urinary tract pathogens in children from central Romania. Exp Ther Med 22(1):1–7CrossRef
33.
Zurück zum Zitat Khodabandeh M, Mohammadi M, Abdolsalehi MR, Hasannejad-Bibalan M, Gholami M, Alvandimanesh A et al (2020) High-level aminoglycoside resistance in Enterococcus faecalis and Enterococcus faecium; as a serious threat in hospitals. Infect Disord Drug Targets (Former Curr Drug Targets Infect Disord) 20(2):223–8 Khodabandeh M, Mohammadi M, Abdolsalehi MR, Hasannejad-Bibalan M, Gholami M, Alvandimanesh A et al (2020) High-level aminoglycoside resistance in Enterococcus faecalis and Enterococcus faecium; as a serious threat in hospitals. Infect Disord Drug Targets (Former Curr Drug Targets Infect Disord) 20(2):223–8
34.
Zurück zum Zitat Fesharakinia A, Malekaneh M, Hooshyar H, Aval M, Gandomy-Sany F (2012) The survey of bacterial etiology and their resistance to antibiotics of urinary tract infections in children of Birjand city. J Birjand Univ Med Sci 19(2):208–215 Fesharakinia A, Malekaneh M, Hooshyar H, Aval M, Gandomy-Sany F (2012) The survey of bacterial etiology and their resistance to antibiotics of urinary tract infections in children of Birjand city. J Birjand Univ Med Sci 19(2):208–215
35.
Zurück zum Zitat Motamedifar M, Zamani K, Hassanzadeh Y, Pashoutan S (2016) Bacterial etiologies and antibiotic susceptibility pattern of urinary tract infections at the pediatric ward of Dastgheib hospital, Shiraz, Iran: a three-year study (2009–2011). Arch Clin Infect Dis. https://doi.org/10.5812/archcid.28973CrossRef Motamedifar M, Zamani K, Hassanzadeh Y, Pashoutan S (2016) Bacterial etiologies and antibiotic susceptibility pattern of urinary tract infections at the pediatric ward of Dastgheib hospital, Shiraz, Iran: a three-year study (2009–2011). Arch Clin Infect Dis. https://​doi.​org/​10.​5812/​archcid.​28973CrossRef
36.
Zurück zum Zitat Fallah F, Parhiz S, Azimi L (2018) Distribution and antibiotic resistance pattern of bacteria isolated from patients with community-acquired urinary tract infections in Iran: a cross-sectional study. Int J Health Stud Fallah F, Parhiz S, Azimi L (2018) Distribution and antibiotic resistance pattern of bacteria isolated from patients with community-acquired urinary tract infections in Iran: a cross-sectional study. Int J Health Stud
37.
Zurück zum Zitat Molazade A, Gholami M, Shahi A, Najafipour S, Mobasheri F, Ashraf Mansuri J, et al. (2014) Evaluation of Antibiotic Resistance Pattern of Isolated Gram-Negative Bacteria from Urine Culture of Hospitalized patients in Different Wards of Vali-Asr Hospital in Fasa During the Years 2012 and 2013. J Fasa Univ Med Sci/Majallah-i Danishgah-i Ulum-i Pizishki-i Fasa. https://doi.org/10.29252/jmj.12.3.22 Molazade A, Gholami M, Shahi A, Najafipour S, Mobasheri F, Ashraf Mansuri J, et al. (2014) Evaluation of Antibiotic Resistance Pattern of Isolated Gram-Negative Bacteria from Urine Culture of Hospitalized patients in Different Wards of Vali-Asr Hospital in Fasa During the Years 2012 and 2013. J Fasa Univ Med Sci/Majallah-i Danishgah-i Ulum-i Pizishki-i Fasa. https://​doi.​org/​10.​29252/​jmj.​12.​3.​22
38.
Zurück zum Zitat Haghgoo SM, Varshochi M, Sabour S, Askari E, Moaddab SR (2014) The prevalence and antibiotic susceptibility pattern of isolated microorganisms from hospitalized patients with heart diseases. J Isfahan Med School. 31(260) Haghgoo SM, Varshochi M, Sabour S, Askari E, Moaddab SR (2014) The prevalence and antibiotic susceptibility pattern of isolated microorganisms from hospitalized patients with heart diseases. J Isfahan Med School. 31(260)
39.
Zurück zum Zitat Jarsiah P, Alizadeh A, Mehdizadeh E, Ataee R, Khanalipour N (2014) Evaluation of antibiotic resistance model of Escherichia coli in urine culture samples at Kian hospital lab in Tehran, 2011–2012. J Mazandaran Univ Med Sci 24(111):78–83 Jarsiah P, Alizadeh A, Mehdizadeh E, Ataee R, Khanalipour N (2014) Evaluation of antibiotic resistance model of Escherichia coli in urine culture samples at Kian hospital lab in Tehran, 2011–2012. J Mazandaran Univ Med Sci 24(111):78–83
40.
Zurück zum Zitat Ramazanzadeh R, Moradi G, Zandi S, Mohammadi S, Rouhi S, Pourzare M et al (2016) A survey of contamination rate and antibiotic resistant of Gram-negative bacteria isolated from patients in various wards of Toohid and Besat Hospitals of Sanandaj city during 2013–2014 years. Pajouhan Scientific Journal 14(3):11–19CrossRef Ramazanzadeh R, Moradi G, Zandi S, Mohammadi S, Rouhi S, Pourzare M et al (2016) A survey of contamination rate and antibiotic resistant of Gram-negative bacteria isolated from patients in various wards of Toohid and Besat Hospitals of Sanandaj city during 2013–2014 years. Pajouhan Scientific Journal 14(3):11–19CrossRef
41.
Zurück zum Zitat Laupland KB, Bagshaw SM, Gregson DB, Kirkpatrick AW, Ross T, Church DL (2005) Intensive care unit-acquired urinary tract infections in a regional critical care system. Crit Care 9(2):1–6CrossRef Laupland KB, Bagshaw SM, Gregson DB, Kirkpatrick AW, Ross T, Church DL (2005) Intensive care unit-acquired urinary tract infections in a regional critical care system. Crit Care 9(2):1–6CrossRef
42.
Zurück zum Zitat Majumder M, Ahmed T, Hossain D, Begum S (2014) Bacteriology and antibiotic sensitivity patterns of urinary tract infections in a tertiary hospital in Bangladesh. Mymensingh Med J 23(1):99–104PubMed Majumder M, Ahmed T, Hossain D, Begum S (2014) Bacteriology and antibiotic sensitivity patterns of urinary tract infections in a tertiary hospital in Bangladesh. Mymensingh Med J 23(1):99–104PubMed
43.
Zurück zum Zitat Yazdi MKS, Azarsa M, Shirazi MH, Rastegar-Lari A, Owlia P, Mehrabadi JF et al (2012) The frequency of extended spectrum beta lactamase and CTX MI of Escherichia coli isolated from the urine tract infection of patients by phenotypic and PCR methods in the city of Khoy in Iran. J Zanjan Univ Med Sci Health Serv 19(77):53–61 Yazdi MKS, Azarsa M, Shirazi MH, Rastegar-Lari A, Owlia P, Mehrabadi JF et al (2012) The frequency of extended spectrum beta lactamase and CTX MI of Escherichia coli isolated from the urine tract infection of patients by phenotypic and PCR methods in the city of Khoy in Iran. J Zanjan Univ Med Sci Health Serv 19(77):53–61
Metadaten
Titel
Evaluating the pattern of antibiotic resistance of urinary tract infection (UTI)-causing bacteria in the urine culture samples of patients in the infectious ward of Imam Khomeini Hospital, Kermanshah, in Iran from 2016–2018
verfasst von
Maria Shirvani
Ali Keramati
Mojtaba Esmaeli
Publikationsdatum
01.12.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
African Journal of Urology / Ausgabe 1/2023
Print ISSN: 1110-5704
Elektronische ISSN: 1961-9987
DOI
https://doi.org/10.1186/s12301-023-00364-4

Weitere Artikel der Ausgabe 1/2023

African Journal of Urology 1/2023 Zur Ausgabe

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.